This is a routine divestment by a pre-IPO venture investor. The sale is small relative to market cap and does not imply any change in business fundamentals. Monitor for any Form 4 filings to confirm execution, but no immediate trading action is warranted.
Price Chart
Executive Summary
Atlas Venture Opportunity Fund I, L.P., a major early investor, filed a Form 144 notice of intent to sell 64,411 shares of Dyne Therapeutics common stock, valued at approximately $1.33M at the filing date. This represents a routine insider sale by a pre-IPO venture backer and does not signal a change in company outlook.
Key Facts
- Atlas Venture Opportunity Fund I, L.P. filed Form 144 to sell 64,411 shares of Dyne Therapeutics common stock.
- The estimated market value of the proposed sale is approximately $1.33 million.
- The shares were acquired in a private placement on August 7, 2020.
- The insider has sold no other securities in the past 3 months.
Financial Impact
Sale of 64,411 shares valued at approximately $1.33 million, representing a small fraction of the company's $3.6B market cap.
Risk Factors
- None directly from this filing; a large block trade if executed could cause minor short-term price pressure.
- Insider selling by large holders, if sustained, may signal reduced long-term conviction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-045818 |
| Document: 0001628280-26-045818-index.html | 0001628280-26-045818 |
| Document: 0001628280-26-045818.txt | 0001628280-26-045818 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access